U.S. Markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2900-0.1500 (-6.15%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.25
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.8000
52 Week Low 30.8100
50-Day Moving Average 32.8672
200-Day Moving Average 33.3436

Share Statistics

Avg Vol (3 month) 34.47M
Avg Vol (10 day) 33.18M
Shares Outstanding 5120.82M
Implied Shares Outstanding 6N/A
Float 8126.6M
% Held by Insiders 10.04%
% Held by Institutions 131.42%
Shares Short (Oct 14, 2021) 420.97M
Short Ratio (Oct 14, 2021) 44.99
Short % of Float (Oct 14, 2021) 416.57%
Short % of Shares Outstanding (Oct 14, 2021) 416.56%
Shares Short (prior month Sep 14, 2021) 423.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.63%
Return on Equity (ttm)-28.27%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.23M
Net Income Avi to Common (ttm)-26.05M
Diluted EPS (ttm)-0.7120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)142.43M
Total Cash Per Share (mrq)1.12
Total Debt (mrq)4.72k
Total Debt/Equity (mrq)0.00
Current Ratio (mrq)81.19
Book Value Per Share (mrq)1.15

Cash Flow Statement

Operating Cash Flow (ttm)-15.86M
Levered Free Cash Flow (ttm)-9.03M